Pharmacological Inhibition of BAD Ser99 Phosphorylation Enhances the Efficacy of Cisplatin in Ovarian Cancer by Inhibition of Cancer Stem Cell-like Behavior

10.1021/acsptsci.0c00064

Saved in:

Bibliographic Details
Main Authors:	Wang, Yanxin, Chiou, Yi-Shiou, Chong, Qing-Yun, Zhang, Mengyi, Rangappa, Kanchuragoppal S, Ma, Lan, Zhu, Tao, Kumar, Alan Prem, Huang, Ruby Yun-Ju, Pandey, Vijay, Basappa, Lobie, Peter E
Other Authors:	CANCER SCIENCE INSTITUTE OF SINGAPORE
Format:	Article
Language:	English
Published:	AMER CHEMICAL SOC 2023
Subjects:	Science & Technology Life Sciences & Biomedicine Chemistry, Medicinal Pharmacology & Pharmacy BAD phosphorylation NPB ovarian cancer cisplatin resistance cancer stem cell PHASE-III TRIAL INTERGROUP TRIAL CARBOPLATIN-PACLITAXEL 1ST-LINE TREATMENT SURVIVAL PROTEIN MECHANISMS THERAPY DEATH DRUG
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/245936
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore
Language:	English

id	sg-nus-scholar.10635-245936
record_format	dspace
spelling	sg-nus-scholar.10635-2459362023-11-14T06:55:06Z Pharmacological Inhibition of BAD Ser99 Phosphorylation Enhances the Efficacy of Cisplatin in Ovarian Cancer by Inhibition of Cancer Stem Cell-like Behavior Wang, Yanxin Chiou, Yi-Shiou Chong, Qing-Yun Zhang, Mengyi Rangappa, Kanchuragoppal S Ma, Lan Zhu, Tao Kumar, Alan Prem Huang, Ruby Yun-Ju Pandey, Vijay Basappa Lobie, Peter E CANCER SCIENCE INSTITUTE OF SINGAPORE Science & Technology Life Sciences & Biomedicine Chemistry, Medicinal Pharmacology & Pharmacy BAD phosphorylation NPB ovarian cancer cisplatin resistance cancer stem cell PHASE-III TRIAL INTERGROUP TRIAL CARBOPLATIN-PACLITAXEL 1ST-LINE TREATMENT SURVIVAL PROTEIN MECHANISMS THERAPY DEATH DRUG 10.1021/acsptsci.0c00064 ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE 3 6 1083-1099 2023-11-14T06:30:28Z 2023-11-14T06:30:28Z 2020-12-11 2023-11-13T05:14:51Z Article Wang, Yanxin, Chiou, Yi-Shiou, Chong, Qing-Yun, Zhang, Mengyi, Rangappa, Kanchuragoppal S, Ma, Lan, Zhu, Tao, Kumar, Alan Prem, Huang, Ruby Yun-Ju, Pandey, Vijay, Basappa, Lobie, Peter E (2020-12-11). Pharmacological Inhibition of BAD Ser99 Phosphorylation Enhances the Efficacy of Cisplatin in Ovarian Cancer by Inhibition of Cancer Stem Cell-like Behavior. ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE 3 (6) : 1083-1099. ScholarBank@NUS Repository. https://doi.org/10.1021/acsptsci.0c00064 2575-9108 https://scholarbank.nus.edu.sg/handle/10635/245936 en AMER CHEMICAL SOC Elements
institution	National University of Singapore
building	NUS Library
continent	Asia
country	Singapore Singapore
content_provider	NUS Library
collection	ScholarBank@NUS
language	English
topic	Science & Technology Life Sciences & Biomedicine Chemistry, Medicinal Pharmacology & Pharmacy BAD phosphorylation NPB ovarian cancer cisplatin resistance cancer stem cell PHASE-III TRIAL INTERGROUP TRIAL CARBOPLATIN-PACLITAXEL 1ST-LINE TREATMENT SURVIVAL PROTEIN MECHANISMS THERAPY DEATH DRUG
spellingShingle	Science & Technology Life Sciences & Biomedicine Chemistry, Medicinal Pharmacology & Pharmacy BAD phosphorylation NPB ovarian cancer cisplatin resistance cancer stem cell PHASE-III TRIAL INTERGROUP TRIAL CARBOPLATIN-PACLITAXEL 1ST-LINE TREATMENT SURVIVAL PROTEIN MECHANISMS THERAPY DEATH DRUG Wang, Yanxin Chiou, Yi-Shiou Chong, Qing-Yun Zhang, Mengyi Rangappa, Kanchuragoppal S Ma, Lan Zhu, Tao Kumar, Alan Prem Huang, Ruby Yun-Ju Pandey, Vijay Basappa Lobie, Peter E Pharmacological Inhibition of BAD Ser99 Phosphorylation Enhances the Efficacy of Cisplatin in Ovarian Cancer by Inhibition of Cancer Stem Cell-like Behavior
description	10.1021/acsptsci.0c00064
author2	CANCER SCIENCE INSTITUTE OF SINGAPORE
author_facet	CANCER SCIENCE INSTITUTE OF SINGAPORE Wang, Yanxin Chiou, Yi-Shiou Chong, Qing-Yun Zhang, Mengyi Rangappa, Kanchuragoppal S Ma, Lan Zhu, Tao Kumar, Alan Prem Huang, Ruby Yun-Ju Pandey, Vijay Basappa Lobie, Peter E
format	Article
author	Wang, Yanxin Chiou, Yi-Shiou Chong, Qing-Yun Zhang, Mengyi Rangappa, Kanchuragoppal S Ma, Lan Zhu, Tao Kumar, Alan Prem Huang, Ruby Yun-Ju Pandey, Vijay Basappa Lobie, Peter E
author_sort	Wang, Yanxin
title	Pharmacological Inhibition of BAD Ser99 Phosphorylation Enhances the Efficacy of Cisplatin in Ovarian Cancer by Inhibition of Cancer Stem Cell-like Behavior
title_short	Pharmacological Inhibition of BAD Ser99 Phosphorylation Enhances the Efficacy of Cisplatin in Ovarian Cancer by Inhibition of Cancer Stem Cell-like Behavior
title_full	Pharmacological Inhibition of BAD Ser99 Phosphorylation Enhances the Efficacy of Cisplatin in Ovarian Cancer by Inhibition of Cancer Stem Cell-like Behavior
title_fullStr	Pharmacological Inhibition of BAD Ser99 Phosphorylation Enhances the Efficacy of Cisplatin in Ovarian Cancer by Inhibition of Cancer Stem Cell-like Behavior
title_full_unstemmed	Pharmacological Inhibition of BAD Ser99 Phosphorylation Enhances the Efficacy of Cisplatin in Ovarian Cancer by Inhibition of Cancer Stem Cell-like Behavior
title_sort	pharmacological inhibition of bad ser99 phosphorylation enhances the efficacy of cisplatin in ovarian cancer by inhibition of cancer stem cell-like behavior
publisher	AMER CHEMICAL SOC
publishDate	2023
url	https://scholarbank.nus.edu.sg/handle/10635/245936
_version_	1783955449222004736

Pharmacological Inhibition of BAD Ser99 Phosphorylation Enhances the Efficacy of Cisplatin in Ovarian Cancer by Inhibition of Cancer Stem Cell-like Behavior

Similar Items